Abstract
To reduce health care costs and improve care, payers and physician groups are switching to quality-based and episodic or bundled-care models. Disease progression and associated costs may affect these models, particularly if such programs do not account for differences in disease severity and progression risk within the cohort. This study estimated the incremental cost of disease progression in patients diagnosed with chronic lymphoid leukemia (CLL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma (NHL) and compared costs among patients with and without progression. This was a retrospective study using U.S. administrative claims data from commercial and Medicare Advantage health care enrollees with evidence of CLL, AML, and NHL and systemic antineoplastic agent use from July 1, 2006 to August 31, 2014. Outcome measures included disease progression, 12-month health care costs, and 3-year cumulative predictive health care costs. Of 1,056 patients with CLL, 514 patients with AML, and 7,601 patients with NHL, 31.1% of patients with CLL, 63.8% of those with AML, and 36.9% of those with NHL had evidence of disease progression. Among patients with CLL and NHL, adjusted and unadjusted health care costs were significantly higher...Continue Reading
References
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J KeatingE J Freireich
Feb 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KantarjianE J Freireich
Jul 19, 2002·Archives of Internal Medicine·Joseph MenzinRajiv Mallick
Apr 5, 2003·Blood·Paul A HamlinCraig H Moskowitz
Sep 13, 2006·Leukemia & Lymphoma·Lucie KutikovaWilliam H Crown
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
Feb 19, 2011·American Journal of Epidemiology·Hude QuanVijaya Sundararajan
Jul 13, 2011·Leukemia & Lymphoma·Roy BeveridgeCarolina Reyes
May 20, 2014·Journal of Oncology Practice·Lee N Newcomer
Jul 10, 2014·Journal of Oncology Practice·Lee N NewcomerMonica Perkins
Oct 5, 2014·Blood·Constantine S TamMichael J Keating
Mar 15, 2015·Journal of the American Medical Informatics Association : JAMIA·F Phil CartagenaHoward S Goldberg
Jul 1, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carla CasuloJonathan W Friedberg
Feb 1, 2017·Clinical Pharmacology and Therapeutics·L K MortimerR M Kline
Aug 19, 2017·Endoscopic Ultrasound·UNKNOWN Chinese Thoracic Society, UNKNOWN Chinese Alliance against Lung Cancer
Citations
Jan 9, 2020·Current Medical Research and Opinion·Debra E IrwinErika Szabo
Feb 6, 2020·Journal of Managed Care & Specialty Pharmacy·Ankur A DashputreJustin Gatwood
May 14, 2021·Journal of Blood Medicine·Anna Forsythe, Karen Sandman